Hyperkalaemia in congestive heart failure patients using ACE inhibitors and spironolactone

Nephrology Dialysis Transplantation

Volumn 18, Issue 9, 2003, Pages 1814-1819

  Cruz, Constança S ^a   Cruz, Álvaro A ^b   de Souza, Carlos A Marcílio ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Angiotensin converting enzyme inhibitors; Drug induced hyperkalaemia; Heart failure; Hyperkalaemia; Spironolactone

Indexed keywords

CAPTOPRIL; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FUROSEMIDE; POTASSIUM; SPIRONOLACTONE;

ADULT; AGED; BRAZIL; CLINICAL FEATURE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EXPOSURE; DRUG USE; FEMALE; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; HYPERKALEMIA; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL RECORD; MORTALITY; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; COHORT STUDIES; DIURETICS; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; HYPERKALEMIA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SPIRONOLACTONE;

EID: 0042885922     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg295     Document Type: Review

References (15)

1. Pitt B, Zannad F, Remme WJ et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999; 341: 709-717
2. Beck LH. The aging kidney: defending a delicate balance of fluid and electrolytes. Geriatrics 2000; 55: 26-28, 31-32
3. Task Force of Working Group on Heart Failure of the European Society of Cardiology. The treatment of heart failure. Eur Heart J 1997; 18: 736-753
4. Wynckel A, Ebikili B, Mellin JP et al. Long-term follow-up of acute renal failure caused by ACE inhibitors. Am J Hypertens 1998; 11: 1080-1086
5. Michelis MF. Hyperkalemia in the elderly. Am J Kidney Dis 1990; 16: 296-299
6. Large DM, Laing I. Hyperkalemia in diabetes mellitus: potential hazards of co-existing hyporeninemic. Postgrad Med J 1984; 60: 370-373
7. Perazella MA, Mahnensmith RL. Hyperkalemia in the elderly: drugs exacerbate impaired potassium homeostasis. J Gen Intern Med 1997; 646-656
8. Ljungman S, Kjekshus J, Swedberg K. Renal function in heart failure (CONSENSUS). Am J Cadiol 1992; 70: 479-487
9. Hatcher J. Plasma electrolytes and flame photometry. Nurs Mirror Midwives J 1973; 136: 38-39
10. Helger R, Rindfrey H, Hilgenfeldt J. Direct estimation of creatinine in serum and urine without deproteinization using modified Jaffé method. Z Klin Chem Klin Biochem 1974; 12: 344-349
11. Ahuja TS, Freeman JR et al. Predictors of the development of hyperkalemia in patients using ACE inhibitors. Am J Nephrol 2000; 20: 268-272
12. Pitt B, Pierad LA, Bilge A et al. Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure: the Randomized Aldactone Evaluation Study (RALES). Am J Cardiol 1996; 78: 902-907
13. Pitt B. ACE inhibitor co-therapy in patients with heart failure: Rationale for the Randomized Aldactone Evaluation Study (RALES). Eur Heart J 1995; 16: S107-S110
14. Georges B, Beguin C, Jadoul M. Spironolactone, and congestive heart failure. Lancet 2000; 355: 1369-1370
15. Schepkens H, Vanholder R, Billiouw JM, Lameire N. Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases. Am J Med 2001; 110: 438-441